Pages that link to "Q57157188"
Jump to navigation
Jump to search
The following pages link to Justin Guinney (Q57157188):
Displaying 50 items.
- Inferring causal molecular networks: empirical assessment through a community-based effort (Q28530068) (← links)
- Predictive genes in adjacent normal tissue are preferentially altered by sCNV during tumorigenesis in liver cancer and may rate limiting (Q28742950) (← links)
- Prediction of overall survival for patients with metastatic castration-resistant prostate cancer: development of a prognostic model through a crowdsourced challenge with open clinical trial data (Q30490354) (← links)
- Systematic analysis of challenge-driven improvements in molecular prognostic models for breast cancer (Q30566197) (← links)
- GSVA: gene set variation analysis for microarray and RNA-seq data. (Q30586230) (← links)
- The NIH BD2K center for big data in translational genomics (Q30980407) (← links)
- PERSONALIZED HYPOTHESIS TESTS FOR DETECTING MEDICATION RESPONSE IN PARKINSON DISEASE PATIENTS USING iPHONE SENSOR DATA. (Q31037307) (← links)
- Analysis of sample set enrichment scores: assaying the enrichment of sets of genes for individual samples in genome-wide expression profiles (Q33252085) (← links)
- Modeling cancer progression via pathway dependencies (Q33320177) (← links)
- F-Seq: a feature density estimator for high-throughput sequence tags (Q33368553) (← links)
- Prediction of overall survival in stage II and III colon cancer beyond TNM system: a retrospective, pooled biomarker study (Q33608167) (← links)
- CTCF haploinsufficiency destabilizes DNA methylation and predisposes to cancer (Q33692429) (← links)
- Modeling RAS phenotype in colorectal cancer uncovers novel molecular traits of RAS dependency and improves prediction of response to targeted agents in patients (Q34078212) (← links)
- Correlation set analysis: detecting active regulators in disease populations using prior causal knowledge (Q34207439) (← links)
- Genome-wide methylation profiles reveal quantitative views of human aging rates (Q34313440) (← links)
- Genomic strategy for targeting therapy in castration-resistant prostate cancer (Q34605452) (← links)
- Molecular markers identify subtypes of stage III colon cancer associated with patient outcomes (Q34665492) (← links)
- Improving breast cancer survival analysis through competition-based multidimensional modeling (Q34720254) (← links)
- Stepwise group sparse regression (SGSR): gene-set-based pharmacogenomic predictive models with stepwise selection of functional priors (Q34988221) (← links)
- Impact of centralization on aCGH-based genomic profiles for precision medicine in oncology (Q35128506) (← links)
- Evidence for type II cells as cells of origin of K-Ras-induced distal lung adenocarcinoma (Q35882329) (← links)
- A 10-gene progenitor cell signature predicts poor prognosis in lung adenocarcinoma. (Q36036418) (← links)
- The consensus molecular subtypes of colorectal cancer (Q36258187) (← links)
- A high-throughput molecular data resource for cutaneous neurofibromas. (Q36343064) (← links)
- Integrating genetic association, genetics of gene expression, and single nucleotide polymorphism set analysis to identify susceptibility Loci for type 2 diabetes mellitus (Q36402184) (← links)
- rCGH: a comprehensive array-based genomic profile platform for precision medicine (Q36845431) (← links)
- Impact of bioinformatic procedures in the development and translation of high-throughput molecular classifiers in oncology. (Q37100056) (← links)
- Sayan Mukherjee (Q37392297) (← links)
- Genomic Determinants of Protein Abundance Variation in Colorectal Cancer Cells. (Q38602104) (← links)
- Consensus molecular subtypes and the evolution of precision medicine in colorectal cancer (Q39066439) (← links)
- Social interactomes for enabling research communities (Q39103589) (← links)
- BRAF V600E Mutant Colorectal Cancer Subtypes Based on Gene Expression (Q39646999) (← links)
- Database of genomic biomarkers for cancer drugs and clinical targetability in solid tumors (Q39988198) (← links)
- KRAS mutation and Consensus Molecular Subtypes 2 and 3 are independently associated with reduced immune infiltration and reactivity in colorectal cancer. (Q42778262) (← links)
- Community mining of open clinical trial data. (Q48633893) (← links)
- Multi-targeting Drug Community Challenge (Q49614296) (← links)
- Colorectal Cancer Consensus Molecular Subtypes Translated to Preclinical Models Uncover Potentially Targetable Cancer Cell Dependencies (Q49837351) (← links)
- Reply to the letter to the editor 'Including lynch syndrome in personalized prognostication and follow-up of stage II and III colon cancer' by Sciallero et al. (Q50089378) (← links)
- The Immune Landscape of Cancer. (Q52720878) (← links)
- Functional precision medicine identifies novel druggable targets and therapeutic options in head and neck cancer. (Q52723099) (← links)
- Traditional and systems biology based drug discovery for the rare tumor syndrome neurofibromatosis type 2. (Q55383186) (← links)
- Pharmacological and genomic profiling of neurofibromatosis type 1 plexiform neurofibroma-derived schwann cells. (Q55471707) (← links)
- Estimating variable structure and dependence in multitask learning via gradients (Q56906096) (← links)
- Alternative models for sharing confidential biomedical data (Q56985318) (← links)
- A cancer pharmacogenomic screen powering crowd-sourced advancement of drug combination prediction (Q56985387) (← links)
- Spatiotemporal loss of NF1 in Schwann cell lineage leads to different types of cutaneous neurofibroma susceptible to modification by the Hippo pathway (Q57801671) (← links)
- Colorectal premalignancy is associated with consensus molecular subtypes 1 and 2 (Q58588233) (← links)
- Combining accurate tumor genome simulation with crowdsourcing to benchmark somatic structural variant detection (Q58606919) (← links)
- Probing the chemical-biological relationship space with the Drug Target Explorer (Q58765551) (← links)
- Cutaneous neurofibromas in the genomics era: current understanding and open questions (Q60787182) (← links)